Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Hemophilia Gene Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Spark Therapeutics
BioMarin
Freeline Therapeutics
uniQure
Sangamo Therapeutics
Sanofi
Ultragenyx
By Type:
Lentivirus-Based
AAV-Based
By Application:
Hemophilia B
Hemophilia A
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Hemophilia Gene Therapy Market Overview 2018-2029
-
1.1 China Hemophilia Gene Therapy Industry Development Overview
-
1.2 China Hemophilia Gene Therapy Industry Development History
-
1.3 China Hemophilia Gene Therapy Industry Market Size (2018-2029)
-
1.4 China Hemophilia Gene Therapy Market Analysis by Type from Production Side
-
1.4.1 China Hemophilia Gene Therapy Production Volume, Production Value and Growth Rate of Lentivirus-Based (2018-2029)
-
1.4.2 China Hemophilia Gene Therapy Production Volume, Production Value and Growth Rate of AAV-Based (2018-2029)
-
1.5 China Hemophilia Gene Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Hemophilia Gene Therapy Sales Volume, Sales Value and Growth Rate of Hemophilia B (2018-2029)
-
1.5.2 China Hemophilia Gene Therapy Sales Volume, Sales Value and Growth Rate of Hemophilia A (2018-2029)
-
1.6 China Hemophilia Gene Therapy Market Analysis by Region
-
1.6.1 North China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Hemophilia Gene Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Hemophilia Gene Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Hemophilia Gene Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Hemophilia Gene Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Hemophilia Gene Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Hemophilia Gene Therapy Industry Development
Chapter 3 Hemophilia Gene TherapyIndustry Chain Analysis
-
3.1 Hemophilia Gene Therapy Industry Chain
-
3.2 Hemophilia Gene Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Hemophilia Gene Therapy Market
-
3.3 Hemophilia Gene Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Hemophilia Gene Therapy Market
Chapter 4 China Hemophilia Gene Therapy Market, by Type
-
4.1 China Hemophilia Gene Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Hemophilia Gene Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Hemophilia Gene Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Hemophilia Gene Therapy Production Volume and Growth Rate of Lentivirus-Based
-
4.5.2 China Hemophilia Gene Therapy Production Volume and Growth Rate of AAV-Based
Chapter 5 China Hemophilia Gene Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Hemophilia Gene Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Hemophilia Gene Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Hemophilia Gene Therapy Market Size and Growth Rate of Hemophilia B
-
5.5.2 China Hemophilia Gene Therapy Market Size and Growth Rate of Hemophilia A
Chapter 6 China Hemophilia Gene Therapy Market, by Region
-
6.1 China Hemophilia Gene Therapy Production Volume and Production Value, by Region
-
6.2 China Hemophilia Gene Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Hemophilia Gene Therapy Market Analysis
-
7.1 North China Hemophilia Gene Therapy Market, by Type
-
7.2 North China Hemophilia Gene Therapy Market, by Application
Chapter 8 Central China Hemophilia Gene Therapy Market Analysis
-
8.1 Central China Hemophilia Gene Therapy Market, by Type
-
8.2 Central China Hemophilia Gene Therapy Market, by Application
Chapter 9 South China Hemophilia Gene Therapy Market Analysis
-
9.1 South China Hemophilia Gene Therapy Market, by Type
-
9.2 South China Hemophilia Gene Therapy Market, by Application
Chapter 10 East China Hemophilia Gene Therapy Market Analysis
-
10.1 East China Hemophilia Gene Therapy Market, by Type
-
10.2 East China Hemophilia Gene Therapy Market, by Application
Chapter 11 Northeast China Hemophilia Gene Therapy Market Analysis
-
11.1 Northeast China Hemophilia Gene Therapy Market, by Type
-
11.2 Northeast China Hemophilia Gene Therapy Market, by Application
Chapter 12 Southwest China Hemophilia Gene Therapy Market Analysis
-
12.1 Southwest China Hemophilia Gene Therapy Market, by Type
-
12.2 Southwest China Hemophilia Gene Therapy Market, by Application
Chapter 13 Northwest China Hemophilia Gene Therapy Market Analysis
-
13.1 Northwest China Hemophilia Gene Therapy Market, by Type
-
13.2 Northwest China Hemophilia Gene Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 Spark Therapeutics
-
14.1.1 Spark Therapeutics Company Profile
-
14.1.2 Spark Therapeutics Hemophilia Gene Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 BioMarin
-
14.2.1 BioMarin Company Profile
-
14.2.2 BioMarin Hemophilia Gene Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Freeline Therapeutics
-
14.3.1 Freeline Therapeutics Company Profile
-
14.3.2 Freeline Therapeutics Hemophilia Gene Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 uniQure
-
14.4.1 uniQure Company Profile
-
14.4.2 uniQure Hemophilia Gene Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sangamo Therapeutics
-
14.5.1 Sangamo Therapeutics Company Profile
-
14.5.2 Sangamo Therapeutics Hemophilia Gene Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Sanofi
-
14.6.1 Sanofi Company Profile
-
14.6.2 Sanofi Hemophilia Gene Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Ultragenyx
-
14.7.1 Ultragenyx Company Profile
-
14.7.2 Ultragenyx Hemophilia Gene Therapy Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Hemophilia Gene Therapy Industry Research Conclusions
-
15.2 Hemophilia Gene Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Hemophilia Gene Therapy Industry Market Size (2018-2029)
-
Figure China Hemophilia Gene Therapy Production Volume, Production Value and Growth Rate of Lentivirus-Based (2018-2029)
-
Figure China Hemophilia Gene Therapy Production Volume, Production Value and Growth Rate of AAV-Based (2018-2029)
-
Figure China Hemophilia Gene Therapy Sales Volume, Sales Value and Growth Rate of Hemophilia B (2018-2029)
-
Figure China Hemophilia Gene Therapy Sales Volume, Sales Value and Growth Rate of Hemophilia A (2018-2029)
-
Figure North China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Hemophilia Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Hemophilia Gene Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Hemophilia Gene Therapy Market Share by Type in 2018
-
Figure China Hemophilia Gene Therapy Market Share by Type in 2023
-
Figure China Hemophilia Gene Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Hemophilia Gene Therapy Production Volume and Growth Rate of Lentivirus-Based (2018-2023)
-
Figure China Hemophilia Gene Therapy Production Volume and Growth Rate of AAV-Based (2018-2023)
-
Figure China Hemophilia Gene Therapy Market Share by Application in 2018
-
Figure China Hemophilia Gene Therapy Market Share by Application in 2023
-
Figure China Hemophilia Gene Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Hemophilia Gene Therapy Market Size and Growth Rate of Hemophilia B (2018-2023)
-
Figure China Hemophilia Gene Therapy Market Size and Growth Rate of Hemophilia A (2018-2023)
-
Table China Hemophilia Gene Therapy Production Volume by Region (2018-2023)
-
Table China Hemophilia Gene Therapy Production Volume Share by Region (2018-2023)
-
Figure China Hemophilia Gene Therapy Production Volume Share by Region (2018-2023)
-
Table China Hemophilia Gene Therapy Production Value by Region (2018-2023)
-
Table China Hemophilia Gene Therapy Production Value Share by Region (2018-2023)
-
Figure China Hemophilia Gene Therapy Production Value Share by Region (2018-2023)
-
Table China Hemophilia Gene Therapy Sales Volume by Region (2018-2023)
-
Table China Hemophilia Gene Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Hemophilia Gene Therapy Sales Volume Share by Region (2018-2023)
-
Table China Hemophilia Gene Therapy Sales Value by Region (2018-2023)
-
Table China Hemophilia Gene Therapy Sales Value Share by Region (2018-2023)
-
Figure China Hemophilia Gene Therapy Sales Value Share by Region (2018-2023)
-
Table North China Hemophilia Gene Therapy Production Volume by Type (2018-2023)
-
Table North China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Table North China Hemophilia Gene Therapy Sales Volume by Application (2018-2023)
-
Table North China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Hemophilia Gene Therapy Production Volume by Type (2018-2023)
-
Table Central China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Hemophilia Gene Therapy Sales Volume by Application (2018-2023)
-
Table Central China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Hemophilia Gene Therapy Production Volume by Type (2018-2023)
-
Table South China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Table South China Hemophilia Gene Therapy Sales Volume by Application (2018-2023)
-
Table South China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Hemophilia Gene Therapy Production Volume by Type (2018-2023)
-
Table East China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Table East China Hemophilia Gene Therapy Sales Volume by Application (2018-2023)
-
Table East China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Hemophilia Gene Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Hemophilia Gene Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Hemophilia Gene Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Hemophilia Gene Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Hemophilia Gene Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Hemophilia Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Hemophilia Gene Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Hemophilia Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Spark Therapeutics Company Profile
-
Table Spark Therapeutics Hemophilia Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table BioMarin Company Profile
-
Table BioMarin Hemophilia Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Freeline Therapeutics Company Profile
-
Table Freeline Therapeutics Hemophilia Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table uniQure Company Profile
-
Table uniQure Hemophilia Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Sangamo Therapeutics Company Profile
-
Table Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Hemophilia Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Ultragenyx Company Profile
-
Table Ultragenyx Hemophilia Gene Therapy Revenue, Price and Gross (2018-2023)
-
